マーケットレポート詳細
医療用亜酸化窒素の世界市場：タイプ別、用途別2029年予測
Medical Nitrous Oxide Market by Product (Gas, Liquid), Application (Anaesthesia, Pain, Cryosurgery, Surgical Insufflation), End User (Hospital, Home healthcare, Academic, Research Institution), Key Stakeholder & Buying Criteria - Global Forecast to 2029
- 出版元：MarketsandMarkets
出版元について - 発行年：2024年2月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文202ページになります。
- 商品コード：MAM3553
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
医療用亜酸化窒素の世界市場規模は2023年で18億ドル、2029年に28億ドル、市場の平均年成長率は6.6%になると予想されています。
レポートは医療用亜酸化窒素市場の世界市場について2029年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（タイプ別市場、用途別市場、等）を中心に構成されています。また競合状況、主要企業情報（20社）、業界構造分析、バリューチェーン分析などの分析も加味し、医療用亜酸化窒素市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆医療用亜酸化窒素の世界市場予測2018-2029年
・市場規模(US$)
◆タイプ別、市場-2029年
・液体亜酸化窒素
・亜酸化窒素
※(市場規模US$)
◆用途別、市場-2029年
・麻酔/痛み止め
・凍結手術
・外科的送気法
※(市場規模US$)
◆エンドユーザー別、市場-2029年
・病院
・在宅医療設備
・学術機関/研究機関
※(市場規模US$)
◆主要国地域別市場-2029年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメントの細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・技術分析
・プライシング分析
・業界構造分析
・バリューチェーン分析
・エコシステム分析
・ケーススタディ分析
・特許分析
・貿易分析
・競合状況
・市場シェア分析
◆医療用亜酸化窒素の主要企業プロフィール動向
・AIR LIQUIDE
・LINDE PLC
・SOL SPA
・大陽日酸株式会社
・NORCO INC
・SOUTHERN GAS LIMITED
・ELLENBARRIE INDUSTRIAL GASES
・CALOX INC
・STEELMAN GASES PVT LTD
・NEXAIR
・OXYGEN & ARGON WORKS LTD
・GULFCRYO
・CHENGDU TAIYO INDUSTRIAL GASES CO, LTD
・JIANGSU HUAZHONG GAS CO, LTD
・CARBIDE AND CHEMICALS
・AMERICAN WELDING & GAS
・ASIA INDUSTRIAL GASES PTE LTD
・MIDDLESEX GASES & TECHNOLOGY INC
・AMERITANX CYLINDERS
・CRYOCARB
その他企業
・HOLSTON GASES
・AOPL
・BUTLER GAS PRODUCTS COMPANY
・GRUPPO SIAD
・ANDY OXY CO, INC
（全202頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKETS COVERED
・ FIGURE 1 MEDICAL NITROUS OXIDE MARKET SEGMENTATION
1.3.1 REGIONAL SEGMENTATION
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY RESEARCH
2.1.2.1 PRIMARY SOURCES
2.1.2.2 KEY DATA FROM PRIMARY SOURCES
2.1.2.3 KEY INDUSTRY INSIGHTS
2.1.2.4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION METHODOLOGY
・ FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.3 MARKET ESTIMATION
・ FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
・ FIGURE 5 MEDICAL NITROUS OXIDE MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR AIR LIQUIDE S.A.
・ FIGURE 6 MEDICAL NITROUS OXIDE MARKET: DEMAND-SIDE MODELING
・ FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL NITROUS OXIDE MARKET (2023–2029)
・ FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.4 MARKET DATA ESTIMATION AND TRIANGULATION
・ FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 LIMITATIONS
2.6.1 SCOPE-RELATED LIMITATIONS
2.6.2 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
・ TABLE 1 RISK ASSESSMENT: MEDICAL NITROUS OXIDE MARKET
2.8 MEDICAL NITROUS OXIDE MARKET: RECESSION IMPACT
3 EXECUTIVE SUMMARY
・ FIGURE 10 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2023 VS. 2029 (USD MILLION)
・ FIGURE 11 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
・ FIGURE 12 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2023 VS. 2029 (USD MILLION)
・ FIGURE 13 GEOGRAPHICAL SNAPSHOT OF MEDICAL NITROUS OXIDE MARKET
4 PREMIUM INSIGHTS
4.1 MEDICAL NITROUS OXIDE MARKET OVERVIEW
・ FIGURE 14 INCREASING NUMBER OF SURGERIES AND DENTAL PROCEDURES TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE AND COUNTRY (2022)
・ FIGURE 15 LIQUID NITROUS OXIDE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
4.3 MEDICAL NITROUS OXIDE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 16 ASIA PACIFIC REGION TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 MEDICAL NITROUS OXIDE MARKET: REGIONAL MIX
・ FIGURE 17 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.5 MEDICAL NITROUS OXIDE MARKET: DEVELOPED VS. EMERGING ECONOMIES
・ FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 19 MEDICAL NITROUS OXIDE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・ TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 INCREASING NUMBER OF SURGERIES AND DENTAL PROCEDURES
5.2.1.2 GROWING ADOPTION OF NITROUS OXIDE ACROSS VARIOUS MEDICAL SPECIALTIES
5.2.1.3 RISING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN PREVALENCE OF CHRONIC DISEASES
・ FIGURE 20 GLOBAL GERIATRIC POPULATION, BY REGION, 2010–2030 (% OF TOTAL POPULATION)
5.2.1.4 GROWING DEMAND FOR HOME HEALTHCARE
5.2.2 RESTRAINTS
5.2.2.1 POTENTIAL RISKS ASSOCIATED WITH NITROUS OXIDE MISUSE
5.2.2.2 AVAILABILITY OF ALTERNATIVES
5.2.3 OPPORTUNITIES
5.2.3.1 RISING DEMAND FOR PAIN MANAGEMENT
・ FIGURE 21 PREVALENCE OF CHRONIC PAIN AND HIGH-IMPACT CHRONIC PAIN AMONG ADULTS IN US, 2019–2021
5.2.3.2 TECHNOLOGICAL ADVANCEMENTS
5.2.4 CHALLENGES
5.2.4.1 CHANGES IN CALIBRATION STANDARDS
5.2.4.2 LACK OF AWARENESS
5.3 INDUSTRY TRENDS
5.3.1 ADVANCEMENTS IN NITROUS OXIDE DELIVERY SYSTEMS
5.3.2 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 NITROUS OXIDE DELIVERY SYSTEMS
5.4.1.2 MONITORING AND CONTROL SYSTEMS
5.4.1.3 TECHNOLOGICAL INTEGRATION IN ANESTHESIA MACHINES
5.4.2 COMPLEMENTARY TECHNOLOGIES 60
5.4.2.1 PATIENT MONITORING DEVICES
5.4.2.2 SMART DEVICES AND CONNECTIVITY
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 ADVANCED ANESTHETIC AGENTS
5.4.3.2 SURGICAL ROBOTICS
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND OF MEDICAL NITROUS OXIDE, BY PRODUCT
・ TABLE 3 AVERAGE SELLING PRICE OF MEDICAL NITROUS OXIDE, BY PRODUCT TYPE (USD)
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION
5.6 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 4 PORTER’S FIVE FORCES ANALYSIS
5.6.1 INTENSITY OF COMPETITIVE RIVALRY
5.6.2 BARGAINING POWER OF SUPPLIERS
5.6.3 BARGAINING POWER OF BUYERS 62
5.6.4 THREAT OF SUBSTITUTES
5.6.5 THREAT OF NEW ENTRANTS
5.7 TARIFF & REGULATORY ANALYSIS
5.7.1 TARIFF FOR MEDICAL NITROUS OXIDE
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.3 NORTH AMERICA
5.7.3.1 US
・ TABLE 5 US: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.3.2 CANADA
・ TABLE 6 CANADA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.4 EUROPE
・ TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.7.5 ASIA PACIFIC
5.7.5.1 JAPAN
・ TABLE 8 JAPAN: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.5.2 CHINA
・ TABLE 9 CHINA: STANDARDS FOR MEDICAL GAS EQUIPMENT
・ TABLE 10 CHINA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.5.3 INDIA
・ TABLE 11 INDIA: STANDARDS FOR MEDICAL GAS EQUIPMENT
・ TABLE 12 INDIA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.6 LATIN AMERICA AND MIDDLE EAST & AFRICA
・ TABLE 13 LATIN AMERICA AND MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 VALUE CHAIN ANALYSIS
・ FIGURE 22 VALUE CHAIN ANALYSIS
5.9 ECOSYSTEM ANALYSIS
・ TABLE 14 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM MAPPING
・ FIGURE 23 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM
5.10 CASE STUDY ANALYSIS
5.10.1 CASE STUDY: EAST LANCASHIRE TEACHING HOSPITAL NHS FOUNDATION TRUST (ELHT)
5.11 PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS
・ FIGURE 24 PATENT PUBLICATION TRENDS, 2014–2024
5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR MEDICAL NITROUS OXIDE PATENTS (2014–2024)
・ TABLE 15 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MEDICAL NITROUS OXIDE PATENTS
5.11.3 MEDICAL NITROUS OXIDE MARKET: TOP APPLICANTS
・ FIGURE 25 TOP APPLICANTS FOR MEDICAL NITROUS OXIDE PATENTS (2014–2024)
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE PRODUCTS
・ FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
・ TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE END USERS
5.12.2 BUYING CRITERIA
・ FIGURE 27 KEY BUYING CRITERIA FOR END USERS IN MEDICAL NITROUS OXIDE MARKET
・ TABLE 18 KEY BUYING CRITERIA FOR MEDICAL NITROUS OXIDE MARKET
5.13 KEY CONFERENCES & EVENTS IN 2024
・ TABLE 19 MEDICAL NITROUS OXIDE MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.14 TRADE ANALYSIS
5.14.1 TRADE ANALYSIS FOR MEDICAL NITROUS OXIDE
・ FIGURE 28 PRODUCT IMPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND)
・ FIGURE 29 PRODUCT EXPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND)
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
・ FIGURE 30 REVENUE SHIFT IN MEDICAL NITROUS OXIDE MARKET
5.16 UNMET NEEDS ANALYSIS
・ TABLE 20 UNMET NEEDS IN MEDICAL NITROUS OXIDE MARKET
5.16.1 END-USER EXPECTATIONS
・ TABLE 21 END-USER EXPECTATIONS IN MEDICAL NITROUS OXIDE MARKET
6 MEDICAL NITROUS OXIDE MARKET, BY TYPE
6.1 INTRODUCTION
・ TABLE 22 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 23 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
6.2 LIQUID NITROUS OXIDE
6.2.1 RISING CRYOTHERAPY APPLICATIONS TO DRIVE MARKET
・ TABLE 24 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 25 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.3 GASEOUS NITROUS OXIDE
6.3.1 PRECISE DOSAGE CONTROL AND PORTABILITY TO DRIVE MARKET GROWTH
・ TABLE 26 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 27 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
7 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION
7.1 INTRODUCTION
・ TABLE 28 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 29 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
7.2 ANESTHESIA & PAIN RELIEF
7.2.1 WIDE USAGE AS CARRIER FOR OTHER ANESTHETIC GASES TO DRIVE MARKET
・ TABLE 30 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 31 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2022–2029 (USD MILLION)
7.3 CRYOSURGERY
7.3.1 PAINLESSNESS OF CRYOSURGICAL PROCEDURES TO SUPPORT ADOPTION
・ TABLE 32 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 33 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2022–2029 (USD MILLION)
7.4 SURGICAL INSUFFLATION
7.4.1 USE OF NITROUS OXIDE AS INSUFFLATION GAS IN LAPAROSCOPIC AND ENDOSCOPIC SURGERIES TO DRIVE MARKET
・ TABLE 34 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 35 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2022–2029 (USD MILLION)
8 MEDICAL NITROUS OXIDE MARKET, BY END USER
8.1 INTRODUCTION
・ TABLE 36 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 37 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
8.2 HOSPITALS
8.2.1 EXTENSIVE USAGE OF MEDICAL NITROUS OXIDE TO DRIVE MARKET
・ TABLE 38 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 39 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
8.3 HOME CARE SETTINGS
8.3.1 HOME CARE SETTINGS TO WITNESS HIGHEST GROWTH DUE TO RISING PREVALENCE OF CHRONIC DISEASES
・ TABLE 40 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 41 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 COLLABORATION WITH INDUSTRY PARTNERS FOR TECHNOLOGICAL ADVANCES TO SUPPORT GROWTH
・ TABLE 42 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2021 (USD MILLION) 103
・ TABLE 43 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 104
9 MEDICAL NITROUS OXIDE MARKET, BY REGION
9.1 INTRODUCTION
・ TABLE 44 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2018–2021 (USD MILLION)
・ TABLE 45 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2022–2029 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
・ FIGURE 31 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET SNAPSHOT
・ TABLE 46 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 47 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
・ TABLE 48 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 49 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 50 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 51 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 52 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 53 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2.2 US
9.2.2.1 US TO DOMINATE NORTH AMERICAN MEDICAL NITROUS OXIDE MARKET
・ TABLE 54 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 55 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 56 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 57 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 58 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 59 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2.3 CANADA
9.2.3.1 STRINGENT REGULATORY COMPLIANCE TO SUPPORT MARKET GROWTH IN CANADA 114
・ TABLE 60 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 61 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 62 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 63 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 64 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 65 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
・ TABLE 66 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 67 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
・ TABLE 68 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 69 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 70 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 71 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 72 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 73 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 INCREASING HEALTHCARE SPENDING TO DRIVE MARKET
・ TABLE 74 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 75 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 76 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 77 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 78 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 79 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.3 UK
9.3.3.1 INCREASING SURGERIES & DENTAL PROCEDURES TO DRIVE MARKET
・ TABLE 80 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 81 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 82 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 83 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 84 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 85 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.4 FRANCE
9.3.4.1 WELL-ESTABLISHED HEALTHCARE SYSTEM TO DRIVE MARKET
・ TABLE 86 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 87 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 88 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 89 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 90 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 91 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.5 ITALY
9.3.5.1 RAPID GROWTH IN GERIATRIC POPULATION AND RISING LIFE EXPECTANCY TO FAVOR MARKET GROWTH
・ TABLE 92 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 93 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 94 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 95 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 96 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 97 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 INCREASING PREVALENCE OF CANCER TO SUPPORT MARKET GROWTH
・ TABLE 98 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 99 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 100 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 101 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 102 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 103 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.3.7 REST OF EUROPE
・ TABLE 104 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 105 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 106 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 107 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 108 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 109 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
・ FIGURE 32 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET SNAPSHOT
・ TABLE 110 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION)
・ TABLE 111 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
・ TABLE 112 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 113 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 114 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 115 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 116 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 117 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 JAPAN TO HOLD LARGEST SHARE OF APAC MARKET
・ TABLE 118 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 119 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 120 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 121 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 122 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 123 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.3 CHINA
9.4.3.1 STRONG INVESTMENTS IN INFRASTRUCTURAL DEVELOPMENT TO OFFER OPPORTUNITIES FOR MARKET GROWTH
・ TABLE 124 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 125 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 126 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 127 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 128 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 129 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.4 INDIA
9.4.4.1 RISING PROCEDURAL VOLUME TO ENSURE SUSTAINED DEMAND FOR MEDICAL GASES
・ TABLE 130 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 131 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 132 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 133 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 134 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 135 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
・ TABLE 136 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 137 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 138 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 139 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 140 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 141 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 RISING PUBLIC-PRIVATE PARTNERSHIPS FOR HEALTHCARE DEVELOPMENT TO PROMOTE ADOPTION OF MEDICAL NITROUS OXIDE 146
9.5.2 LATIN AMERICA: RECESSION IMPACT
・ TABLE 142 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 143 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 144 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 145 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 146 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 147 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
・ TABLE 148 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION)
・ TABLE 149 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION)
・ TABLE 150 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION)
・ TABLE 151 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
・ TABLE 152 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION)
・ TABLE 153 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
・ TABLE 154 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL NITROUS OXIDE MARKET
10.3 REVENUE ANALYSIS
・ FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL NITROUS OXIDE MARKET, 2018–2022 (USD MILLION)
10.4 MARKET SHARE ANALYSIS
・ FIGURE 34 MEDICAL NITROUS OXIDE MARKET SHARE ANALYSIS (2022)
・ TABLE 155 MEDICAL NITROUS OXIDE MARKET: DEGREE OF COMPETITION
10.5 MARKET RANKING ANALYSIS
・ FIGURE 35 MEDICAL NITROUS OXIDE MARKET RANKING, BY KEY PLAYER, 2022
10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS
10.6.1 STARS
10.6.2 EMERGING LEADERS
10.6.3 PERVASIVE PLAYERS
10.6.4 PARTICIPANTS
・ FIGURE 36 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
10.6.5 COMPANY FOOTPRINT
・ FIGURE 37 MEDICAL NITROUS OXIDE MARKET: COMPANY FOOTPRINT
・ TABLE 156 MEDICAL NITROUS OXIDE MARKET: TYPE FOOTPRINT
・ TABLE 157 MEDICAL NITROUS OXIDE MARKET: APPLICATION FOOTPRINT
・ TABLE 158 MEDICAL NITROUS OXIDE MARKET: END-USER FOOTPRINT
・ TABLE 159 MEDICAL NITROUS OXIDE MARKET: REGIONAL FOOTPRINT
10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES
10.7.1 PROGRESSIVE COMPANIES
10.7.2 RESPONSIVE COMPANIES
10.7.3 DYNAMIC COMPANIES
10.7.4 STARTING BLOCKS
・ FIGURE 38 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
10.7.5 COMPETITIVE BENCHMARKING
10.7.5.1 DETAILED LIST OF KEY STARTUPS/SMES
・ TABLE 160 MEDICAL NITROUS OXIDE: DETAILED LIST OF KEY STARTUPS/SMES
10.7.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
・ TABLE 161 MEDICAL NITROUS OXIDE: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPANY EVALUATION AND FINANCIAL METRICS
・ FIGURE 39 EV/EBITDA OF KEY VENDORS
・ FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MEDICAL NITROUS OXIDE VENDORS
10.10 COMPETITIVE SCENARIO
10.10.1 DEALS
・ TABLE 162 MEDICAL NITROUS OXIDE MARKET: DEALS, JANUARY 2020– JANUARY 2024
10.10.2 EXPANSIONS
・ TABLE 163 MEDICAL NITROUS OXIDE MARKET: EXPANSIONS, JANUARY 2020–JANUARY 2024
11 COMPANY PROFILES
11.1 KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS/SERVICES/SOLUTIONS OFFERED, MNM VIEW, KEY STRENGTHS AND RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS, RECENT DEVELOPMENTS)*
11.1.1 AIR LIQUIDE
・ TABLE 164 AIR LIQUIDE: COMPANY OVERVIEW
・ FIGURE 41 AIR LIQUIDE: COMPANY SNAPSHOT (2022)
11.1.2 LINDE PLC
・ TABLE 165 LINDE PLC: COMPANY OVERVIEW 175
・ FIGURE 42 LINDE PLC: COMPANY SNAPSHOT (2022)
11.1.3 SOL SPA
・ TABLE 166 SOL SPA: COMPANY OVERVIEW
・ FIGURE 43 SOL SPA: COMPANY SNAPSHOT (2022)
11.1.4 TAIYO NIPPON SANSO CORPORATION
・ TABLE 167 TAIYO NIPPON SANSO CORPORATION: COMPANY OVERVIEW
・ FIGURE 44 TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2023)
11.1.5 NORCO INC.
・ TABLE 168 NORCO INC.: COMPANY OVERVIEW 184
11.1.6 SOUTHERN GAS LIMITED
・ TABLE 169 SOUTHERN GAS LIMITED: COMPANY OVERVIEW
・ FIGURE 45 SOUTHERN GAS LIMITED: COMPANY SNAPSHOT (2022)
11.1.7 ELLENBARRIE INDUSTRIAL GASES 187
・ TABLE 170 ELLENBARRIE INDUSTRIAL GASES: COMPANY OVERVIEW
・ FIGURE 46 ELLENBARRIE INDUSTRIAL GASES: COMPANY SNAPSHOT (2020)
11.1.8 CALOX INC.
・ TABLE 171 CALOX INC.: COMPANY OVERVIEW 188
11.1.9 STEELMAN GASES PVT. LTD.
・ TABLE 172 STEELMAN GASES PVT. LTD.: COMPANY OVERVIEW
11.1.10 NEXAIR
・ TABLE 173 NEXAIR: COMPANY OVERVIEW
11.1.11 OXYGEN & ARGON WORKS LTD.
・ TABLE 174 OXYGEN & ARGON WORKS LTD.: COMPANY OVERVIEW
11.1.12 GULFCRYO
・ TABLE 175 GULFCRYO: COMPANY OVERVIEW 193
11.1.13 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.
・ TABLE 176 CHENGDU TAIYO INDUSTRIAL GASES CO. LTD.: COMPANY OVERVIEW
11.1.14 JIANGSU HUAZHONG GAS CO., LTD.
・ TABLE 177 JIANGSU HAUZHONG GAS CO., LTD.: COMPANY OVERVIEW
11.1.15 CARBIDE AND CHEMICALS
・ TABLE 178 CARBIDE AND CHEMICALS: COMPANY OVERVIEW
11.1.16 AMERICAN WELDING & GAS
・ TABLE 179 AMERICAN WELDING & GAS: COMPANY OVERVIEW
11.1.17 ASIA INDUSTRIAL GASES PTE. LTD.
・ TABLE 180 ASIA INDUSTRIAL GASES PTE. LTD.: COMPANY OVERVIEW
11.1.18 MIDDLESEX GASES & TECHNOLOGY INC.
・ TABLE 181 MIDDLESEX GASES & TECHNOLOGIES INC.: COMPANY OVERVIEW
11.1.19 AMERITANX CYLINDERS
・ TABLE 182 AMERITANX CYLINDERS: COMPANY OVERVIEW
11.1.20 CRYOCARB
・ TABLE 183 CRYOCARB: COMPANY OVERVIEW 201
*BUSINESS OVERVIEW, PRODUCTS/SERVICES/SOLUTIONS OFFERED, MNM VIEW, KEY STRENGTHS AND RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS, RECENT DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
11.2 OTHER PLAYERS
11.2.1 HOLSTON GASES
11.2.2 AOPL
11.2.3 BUTLER GAS PRODUCTS COMPANY 203
11.2.4 GRUPPO SIAD
11.2.5 ANDY OXY CO., INC.